Détail du document
Identifiant

doi:10.1007/s00018-022-04225-1...

Auteur
Han, Jinming Chitu, Violeta Stanley, E. Richard Wszolek, Zbigniew K. Karrenbauer, Virginija Danylaité Harris, Robert A.
Langue
en
Editeur

Springer

Catégorie

Life Sciences

Année

2022

Date de référencement

06/04/2022

Mots clés
colony stimulating factor-1 recept... alzheimer’s disease parkinson’s disease huntington’s disease amyotrophic lateral sclerosis multiple sclerosis diseases inhibitors csf-1r
Métrique

Résumé

Microglia are specialized dynamic immune cells in the central nervous system (CNS) that plays a crucial role in brain homeostasis and in disease states.

Persistent neuroinflammation is considered a hallmark of many neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson's disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS) and primary progressive multiple sclerosis (MS).

Colony stimulating factor 1-receptor (CSF-1R) is predominantly expressed on microglia and its expression is significantly increased in neurodegenerative diseases.

Cumulative findings have indicated that CSF-1R inhibitors can have beneficial effects in preclinical neurodegenerative disease models.

Research using CSF-1R inhibitors has now been extended into non-human primates and humans.

This review article summarizes the most recent advances using CSF-1R inhibitors in different neurodegenerative conditions including AD, PD, HD, ALS and MS. Potential challenges for translating these findings into clinical practice are presented.

Han, Jinming,Chitu, Violeta,Stanley, E. Richard,Wszolek, Zbigniew K.,Karrenbauer, Virginija Danylaité,Harris, Robert A., 2022, Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges, Springer

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

Lung cancer risk and exposure to air pollution: a multicenter North China case–control study involving 14604 subjects
lung cancer case–control air pollution never-smokers nomogram model controls lung-related 14604 subjects north polluted consistent smokers quit exposure lung cancer risk air people factor smoking pollution study history